Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Insight Lifetech CoSHSE:688712 -0.09%31 EV-to-FCF is 95.87 as of Jul. 21, 2026, which is 22% below its 10-year median of 122.62. GuruFocus rates SHSE:688712 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Insight Lifetech Co ranks worse than 86.47% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Insight Lifetech Co's Enterprise Value is ¥12,738.9 Mil.
Insight Lifetech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥132.9 Mil. Therefore, Insight Lifetech Co's EV-to-FCF for today is 95.87.
The historical rank and industry rank for Insight Lifetech Co's EV-to-FCF or its related term are showing as below:
SHSE:688712'
s EV-to-FCF Range Over the Past 10 Years
Min: 93.58 Med: 122.62 Max: 158.84
Current: 101.48
During the past 7 years, the highest EV-to-FCF of Insight Lifetech Co was 158.84. The lowest was 93.58. And the median was 122.62.
SHSE:688712's EV-to-FCF is ranked worse than 86.47% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.21
vs SHSE:688712: 101.48
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Insight Lifetech Co (SHSE:688712) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Insight Lifetech Co's PE Ratio (TTM) for today is calculated as:
Insight Lifetech Co's share price for today is ¥33.30.
Insight Lifetech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.270.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Insight Lifetech Co EV-to-FCF Related Terms
Insight Lifetech Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Insight Lifetech Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688712 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, Insight Lifetech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insight Lifetech Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insight Lifetech Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Insight Lifetech Co's EV-to-FCF falls into.
Insight Lifetech Co's current Enterprise Value is ¥12,738.9 Mil.
Insight Lifetech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥132.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insight Lifetech Co (SHSE:688712) has a EV-to-FCF of 95.87 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Insight Lifetech Co and its competitors. This is 22% below median its historical median of 122.62. Over the past decade, Insight Lifetech Co's EV-to-FCF has ranged from 93.58 to 158.84. According to the industry distribution chart, Insight Lifetech Co ranks #358 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 86.5%.
Is Insight Lifetech Co's EV-to-FCF too high?
Insight Lifetech Co's current EV-to-FCF of 95.87 is 22% below median its 10-year median of 122.62. Over the past 10 years, this metric has ranged from a low of 93.58 to a high of 158.84. The Medical Devices & Instruments industry median EV-to-FCF is 23.21. Insight Lifetech Co's value of 95.87 is 313.1% above this industry median. Based on the distribution chart, Insight Lifetech Co ranks #358 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Insight Lifetech Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Insight Lifetech Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Insight Lifetech Co ranks #358 out of 414 companies for EV-to-FCF. This places Insight Lifetech Co in the lower half of its industry. The industry median EV-to-FCF is 23.21. Insight Lifetech Co's value of 95.87 is 313.1% above this benchmark. Historically, Insight Lifetech Co's own EV-to-FCF has ranged from 93.58 to 158.84 over the past decade. While the company's 10-year median is 122.62 vs. the industry median of 23.21, Insight Lifetech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.21, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Insight Lifetech Co's current EV-to-FCF of 95.87 is 313.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Insight Lifetech Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Insight Lifetech Co's current EV-to-FCF is 95.87, which is 22% below median its own 10-year median of 122.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insight Lifetech Co stock overvalued right now?
Insight Lifetech Co (SHSE:688712) has a current EV-to-FCF of 95.87. The current EV-to-FCF is 95.87, which is 22% below median its 10-year median of 122.62 and 313.1% above the Medical Devices & Instruments industry median of 23.21. Insight Lifetech Co's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Insight Lifetech Co (SHSE:688712), the current EV-to-FCF is 95.87 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressMinzhi Street, Hongrongyuan North Station Center, Tower A 2102, North Station Community, Longhua District, Guangdong Province, Shenzhen, CHN, 518000
Insight Lifetech Co Ltd is a medtech company. It is engaged in the research and development, production, and sale of medical devices used in the diagnosis and treatment of cardiovascular diseases. The company's core products are the TruePhysio pressure microcatheter and VivoCardio FFR system.
31GF Score
Get the complete analysis for SHSE:688712
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688712 has been successfully added to your 
